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ABSTRACT
Presbyopia is a condition that affects many as the
lens ages, and is a secondary effect of cataract
surgery. Multifocal lenses for the treatment of
presbyopia have been undergoing cycles of
development and improvement over the past
two decades. The latest advancements have
yielded lenses with a continuous range of optical
powers, otherwise known as continuous transi-
tional focus (CTF) lenses. Modern CTF lenses
provide a more natural experience for patients
while minimizing unwanted optical side effects.
Keywords: Continuous transitional focal lens;
CTF; Multifocal lens; Presbyopia; IOL
INTRODUCTION
Presbyopia is an ophthalmic condition in which
the eye undergoes progressive degeneration and
loses the ability to focus clearly on objects,
particularly at near vision—this is due to phys-
iological changes that are generally caused by
the aging of the eye. These changes are related
to the decrease in elasticity of the lens that leads
to an inability to respond to ciliary muscle
contraction, resulting in the loss of the accom-
modating power of the lens [1]. Spectacles have
been widely used to correct presbyopia, how-
ever, the development of more permanent,
spectacle-free options, such as intraocular lenses
(IOLs), have proved to be an attractive alterna-
tive. The use of IOLs is especially advantageous
in cases in which surgery is required to remove
the damaged original lens (for example, to treat
cataract) which then has to be replaced by an
artificial one in order to restore vision.
The pioneering operation resulting in a suc-
cessful implantation of the first artificial acrylic
lens was performed by Dr. Harold Ridley on 29
November 1949 [2]. Prior to this first implanta-
tion surgery, a number of questions had to be
addressed regarding the appropriate material and
design for the IOL, as well as the techniques for
performing the required surgery and fixing the
IOL in place [3]. While ophthalmic surgeons
have historically been cautious with new
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materials and technologies, scientific focus and
corresponding progress has been accelerating in
recent years, resulting in a more advanced land-
scape. Currently, there are several different types
of IOLs commercially available, and the surgery
itself and implantation of IOLs have become
routine procedures for correcting a range of
conditions. Nevertheless, after nearly 70 years
and 200 million IOL surgeries, ophthalmic sur-
geons still find themselves trying to better
address the same concerns faced by Harold Ridley
leading up to the first IOL implantation [4].
This brief review describes the evolution of
currently available IOLs to address presbyopia,
and a look toward new technologies, such as
continuous transition focus (CTF) lenses, is
highlighted. This article is based on previously
conducted studies and does not contain any
studies with human participants or animals
performed by any of the authors.
EVOLUTION OF PRESBYOPIC IOLS
IOLs have historically been indicated for treat-
ment of lens opacification, and the materials
and design have evolved over the last 70 years.
The first lenses were rigid and made from
PMMA (poly methyl methacrylate), because Dr.
Ridley had observed that PMMA shrapnel
remained benign in the eyes of World War II
pilots. With the advent of phacoemulsification,
which allowed for much smaller incisions into
the eye for lens removal, foldable lenses were
developed to allow placement through a small
hole. Modern IOLs, made from silicon or intel-
ligently designed polymers, have been found to
provide excellent optical results and a high
degree of patient satisfaction [5].
Whether or not presbyopia is present before
IOL implantation, it is a frequent outcome fol-
lowing surgery, because virtually all IOLs are
unable to adjust in response to patients’ ciliary
muscle contraction. Early lenses used for treat-
ing presbyopia offered single focus corrections,
either for distance or near vision correction. In
many cases patients often received different
powered lenses in each eye (one for distance
and one for near) in order to accommodate for
both conditions. If only one type of lens were to
be used in both of the eyes, the patients would
have required additional spectacles to satisfy
the need for correcting near vision. While
effective, these options are less than ideal,
resulting in reduced patient satisfaction. Alter-
natively, IOLs designed to compensate for lack
of accommodation have been developed to
correct presbyopia, whether it is the principle
concern facing a patient or incidental to catar-
act surgery.
The first multifocal IOL was developed by
Precision-Cosmet (Buffalo, NY, USA), later
transferred to IOLAB Corporation (CA, USA)
and finally Bausch & Lomb (Rochester, NY,
USA), who marketed the lens as NuVue. The
novel design of NuVue facilitated two focal
points [6]. Multiple focal points were created by
combining two radii in a single lens in a bull-
seye pattern, where the center of the bullseye
had one power (power A), the first ring had a
second power (power B), the next ring power A,
then B, and so on. The result is two focal points
simultaneously present in the eye: one for dis-
tance viewing and another for near. The relative
contribution of each focus is modulated by the
pupil diameter under bright and dark lighting
conditions. Other similarly designed lenses
were soon developed, with more than two focal
points, including the TrueVista 68STUV, from
Storz, with three focal points [6, 7].
Another modality of IOL multifocality is the
use of a rotationally asymmetric refractive pro-
file containing an aspheric distance-vision zone
combined with a sector-shaped near-vision
zone in the inferior area of the IOL. This con-
cept is the basis of the multifocal IOL Lentis
Mplus LS-312 (Oculentis GmbH, Berlin, Ger-
many). Studies of this IOL have shown good
near and distance visual outcomes, combined
with postoperative contrast sensitivity within
physiological ranges and a positive impact on
patient quality of life [8–10]. Other studies,
however, have described an increase in optical
aberrations after the implantation of the secto-
rial asymmetric IOL Mplus (Oculentis GmbH,
Berlin, Germany), namely (i) the coma, a third-
order Zernike aberration, associated with the
presence of a high-power refractive sector in the
inferior part of the lens optical zone [11], and
(ii) decreased contrast sensitivity [12].
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The first IOL approved by the USFDA (United
States Food and Drug Administration) for
treatment of presbyopia was the Array lens
manufactured by (the former) Advanced Medi-
cal Optics (now Johnson & Johnson Vision). In
terms of visual acuity, the Array IOL performed
very well in clinical trials and reported a high
level of patient satisfaction [13, 14]. The Array
lens, with its zones of near and distant foci, was
the predecessor to ReZoom (Advanced Medical
Optics, Inc., Santa Ana, CA, USA), a hydropho-
bic acrylic multifocal IOL that contains five
zones of focus which accommodate simultane-
ously both distance and near, under a variety of
lighting conditions [15].
Alternating rings of optical power is not the
only way to produce multiple focal points from
a single lens. Diffractive lenses, as a special
configuration of the Fresnel lens, function by
combining a refractive lens with a cylindrically
symmetric diffractive pattern. The diffractive
pattern acts effectively as a second lens for a
portion of the light, resulting in multiple focal
points. Because a cylindrically symmetrical
diffractive pattern is a series of concentric rings,
diffractive lenses look similar under microscopy
to their refractive counterparts, but the under-
lying physics of operation is very different. The
first diffractive IOLs in the United States were
the 3M 815LE (3M Healthcare) and the Phar-
macia 811E (Advanced Medical Optics, Inc.,
Santa Ana, CA, USA). The 815LE was purchased
by Alcon (Fort Worth, TX, USA) and later
named the ReSTOR, the first diffractive IOL to
be USFDA approved.
One of the key challenges and complaints
with all IOLs—especially multifocal lenses—is
related to the presence of unwanted optical
phenomena such as halos and glare. Halos and
glare appear to patients when light reflects or
diffracts off the sharp edges on the lens [16].
Early IOLs were designed with very soft and
rounded edges with the goal of avoiding irrita-
tion of the capsular bag. Unfortunately, the soft
and round edges can lead to the unintended
consequence of posterior capsule opacification
(PCO) [17]. Changes in design and manufac-
turing to produce sharp edges on the lens
inhibited PCO, but also increased the likelihood
of glare and halos under certain conditions.
With both refractive and diffractive multifocal
IOLS, concentric circles are fabricated into the
lens surface, with sharp discrete boundaries.
These boundaries likewise produce glare and
halos. Efforts to limit these phenomena have





In their 2012 review, Lichtinger and Rootman
elegantly highlight the more prominent tech-
nological improvements made in the develop-
ment of presbyopic IOLs [6]. Advancements
have mostly been targeted towards enhancing
high-level uncorrected and corrected focus for
both distance and near vision, as demonstrated
for Array multifocal IOLs (Allergan, Irvine, USA)
and ReZoom (Advanced Medical Optics),
ReSTOR (Alcon), and M-Flex 630F ?3 (Rayner).
Additionally, Tecnis lenses (Abbott Medical
Optics) are designed to split the light among
near and distance focus regardless of the pupil
size, resulting in a demonstrated superior per-
formance in low light conditions compared
with other multifocal lenses [18]. Other patient
studies have also shown relative ‘‘pupil inde-
pendency’’ leading to better patient acceptance
[19]. In addition, ReSTOR toric lenses incorpo-
rate the astigmatic correction to provide a single
platform to correct astigmatism and improve
near and intermediate vision [6].
Despite the tremendous advancements made
in the field of IOL design and manufacturing,
leading to improved presbyopia and visual
acuity outcomes, none of the above described
IOLs currently on the market remain problem-
free. With ever-growing patient expectations for
visual outcomes following surgery with IOL
implantation, surgeons are often faced with
reports of unwanted dystopic phenomena, such
as halos and glare. This continues to be an issue
regardless of the type of IOL used [20–23]. Other
disadvantages, particularly associated with cur-
rently available accommodative IOL, Crystalens
(Bausch ? Lomb, Rochester, NY, USA), are
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related to tilting and decentration of the lens
caused by capsular contraction and fibrosis [24].
EXTENDED RANGE OF VISION (ERV)
LENSES
ERV lenses use diffractive echelettes, embedded
on the optical surface of the lens, which theo-
retically extend the depth of focus and create a
greater range of useful uncorrected vision.
Negative dispersion refractive technology is also
used to adjust for chromatic and spherical
aberration, improving quality of the image on
the retina, by collapsing the aberration curve as
available light increases. These refractive and
diffractive technologies were used in the Tecnis
Symfony Extended Range of Vision (ERV) IOL
(Johnson and Johnson Vision, Santa Ana, CA,
USA). A recent study of 176 eyes comparing ERV
lenses to monofocal IOLs demonstrated no dif-
ference between groups in uncorrected binocu-
lar visual acuity at distance, however visual
acuity at intermediate and near were signifi-
cantly better in the ERV group [25].
CONTINUOUS TRANSITIONAL
FOCUS (CTF) LENSES
Most multifocal IOL designs, such as bi- and tri-
focal IOLs, generate multiple foci on the retina to
capture the necessary clarity of vision for multi-
ple focal distances. In these types of lens
implants, IOL centration assumes critical
importance since a decentered IOL, relative to
the visual axis, may induce high-order aberra-
tions and decrease post-operative visual function
due to ‘‘looking through’’ diffractive rings of the
IOL instead of the central optical zone as inten-
ded [26]. Thus, decentration could directly lead
to a negative impact on the visual outcomes.
Additionally, as a result of the distinct foci with
different properties in the IOL, severe changes
near the transition points could have a negative
impact on the patient’s vision, as optical distor-
tions are likely to take place. Alternatively, pupil
diameter may also influence the ratio between
distance and near additive power provided by the
IOL. It has been previously described that
patients with a small pupillary diameter (below
3.0 mm) are not good candidates for the tradi-
tional asymmetric refractive multifocal IOL,
especially the Lentis Mplus Toric (Oculentis
GmbH, Berlin, Germany) [26]. Also, patients with
a large pupil are considered at increased risk for
glare dysfunction, and may experience optical
aberrations, diffraction, and photic phenomena
such as glare, starbursts, and halos around light
sources [27, 28]. A recent study comparing
through-focus vision performance and light dis-
turbances of FineVision (PhysIOL, Liège, Bel-
gium) and PanOptix (Alcon Laboratories, Fort
Worth, TX, USA) trifocal IOLs to the Symfony
extended depth of focus IOL was published by
Escandón-Garcı́a and colleagues in Portugal [29].
They found that the trifocal IOLs grant better
performance at near distance while extended
depth of focus IOLs performed better at inter-
mediate distance. Additionally, objective dys-
photopsia was not reduced in extended depth of
focus IOLs as compared to the trifocal IOLs [29].
To address the disadvantages of preexisting
IOLs, a presbyopic IOL, Precizon Presbyopic IOL
(Ophtec BV, Netherlands), has been designed,
applying a novel optical approach. Precizon IOL
is a hybrid material implant based on hydro-
philic acrylic, with a hydrophobic surface
modification (Benz25 material), a C-loop design
with modified haptics, 12.5 mm of total diam-
eter and a 6.00 mm optical zone. The IOL optic
is designated as CTF (‘‘continuous transitional
focus’’) divided into three concentric sectors:
the central sector, of higher diameter, is dedi-
cated to distance correction; two peripheral
sectors present a bimodal (50–50%) distribution
of distance and near correction, and this distri-
bution changes along four segments in each
sector (Fig. 1). This refractive lens provides the
ability for a transition in focus between 11 dis-
tinct segments (five for distance and six for near
vision) within the optical zones. A CTF design
creates a continuous defocus curve (Fig. 2) to
facilitate a sharp image on the retina from
infinity to intermediate, and from intermediate
to near focus [30]. Providing smoother transi-
tion allows for the potential of quicker neu-
roadaptation, more closely mimicking the eye’s
natural process of accommodation and provid-
ing a more natural-like vision.
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A multi-zonal design allows the lens to
maintain the light distribution and exposure on
the foci, regardless of the tilt or decentering of
the lens—addressing challenges related to pupil
size and decentration of earlier designs [31].
In April 2017, Precizon Presbyopic IOL
(Ophtec BV, Groningen, Netherlands) favorably
concluded clinical trials (Clinical Trial
NCT02409771) and results were presented at the
2017 European Society of Cataract and Refractive
Surgeons meeting [32]. The prospective, multi-
center European trial included 60 patients
scheduled for cataract or refractive lens
exchange surgery with a follow-up of 3 months.
Investigators reported good uncorrected visual
acuity at near, intermediate and distance and
80% of patients achieved spectacle indepen-
dence, with an additional 18% requiring occa-
sional spectacle use. The majority of patients did
not report issues with halos and glare, however
approximately one-third of patients did report
little to moderate disturbance. The lens delivered
a concept of an IOL more tolerant to pupil size
and dislocation, receiving its CE marking in May
2017. Additionally, in September 2017, Swiss
Advanced Vision launched EDEN, an IOL that
uses the Instant Focus EDOF (extended-depth-
of-focus) technology that offers continuous
vision with minimized dysphotopsia, while pre-
serving resolution and contrast sensitivity.
As with all IOL implantation to manage
expectations, patient selection is important,
and it is essential to have a perfectly transparent
cornea and to rule out progressive ocular dis-
eases, such as glaucoma or maculopathy, as well
as moderate-to-severe amblyopia, strabismus
and abnormal binocular vision. Notably, pro-
gressive systemic diseases such as diabetes or




CTF lenses are a logical evolution of the previ-
ously commercialized bifocal, trifocal, and
multifocal lenses. CTF lenses can be made by
Fig. 1 General overview of the Precizon CTF (Ophtec BV, Netherlands)
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combining multiple optical elements. Diffrac-
tive lenses have multiple focal points corre-
sponding to the diffraction order. When
combined with a refractive lens, these focal
points are a series where (if fr is the refractive








;m ¼ 1;2;3. . .:
The number of focal points produced by a
diffractive lens depends on the specific details of
photonic engineering, including the number of
concentric rings and the pattern of their
spacing. As more focal points are added to a
diffractive lens, combined with a refractive lens,
the difference between the focal points becomes
indistinguishable to the eye, producing an
apparent continuous gradient of focus on the
retina. Despite precision of design and
fabrication, benefits may be limited by
unwanted optical effects due to sharp edges.
Alternatively, CTF lenses can be fabricated
through a reexamination of purely refractive
designs. The original bifocal refractive lenses
were manufactured by lathe-cutting concentric
rings with different optical powers, producing
Fig. 2 Details of the distribution of the Precizon CTF refractive segments and correspondent near additions according to
the pupillary diameter
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very precise and sharp edges [34]. The Precizon
Presbyopic IOL is manufactured differently than
conventional lathe-cutting, by arranging vary-
ing powers over the lens area in a non-cylin-
drically symmetric fashion.
CTF lenses can provide focus within the entire
depth of field, meaning that the image more
closely mimics the visual experience of the nat-
ural lens. Because the focal points are not limited
to one or two discrete locations, but graduated
over a larger area, some alignment issues are
reduced, making placement of the lens ‘‘more
forgiving’’ and less sensitive to pupil size.
CONCLUSION
Since IOLs were originally conceived, they have
been on a path of continual improvement in
materials and design, always with the goal of
enhancing visual outcomes and patient quality
of life, while limiting complications following
surgery. As with many journeys of technological
development, the path has been nonlinear, and
the latest developments in IOLs for treatment of
presbyopia are no exception. Layers of tech-
nology with corresponding challenges in man-
ufacturing have been added with success, and
much has been learned regarding unintended
optical phenomena. However, as each layer of
complexity is added, the required uniformity
and precision of the subject increases. It should
be noted that the human eye is not a precision
piece of laser optics but contains natural devi-
ation from uniformity. Optimally performing
IOLs for treatment of presbyopia allow for
achievement of full spectacle independence,
with continual focus from distant to near, while
reducing unwanted optical effects. Further
developments of CTF lens technology, with
improvements in the distance central area are
anticipated for a further improvement of the
distance visual acuity and contrast sensitivity.
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